LEAF 1401
Alternative Names: LEAF-1401Latest Information Update: 28 Jul 2024
At a glance
- Originator L.E.A.F. Pharmaceuticals
- Class Antineoplastics
- Mechanism of Action One-carbon group transferase inhibitors; Thymidylate synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Colorectal cancer; Head and neck cancer; Non-small cell lung cancer; Ovarian cancer; Pancreatic cancer; Triple negative breast cancer
Most Recent Events
- 28 Jul 2024 No recent reports of development identified for preclinical development in Colorectal-cancer in USA (IV)
- 28 Jul 2024 No recent reports of development identified for preclinical development in Head-and-neck-cancer in USA (Parenteral)
- 28 Jul 2024 No recent reports of development identified for preclinical development in Non-small-cell-lung-cancer in USA (Parenteral)